HomeCompareXPPLF vs JNJ

XPPLF vs JNJ: Dividend Comparison 2026

XPPLF yields 12.23% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XPPLF wins by $1.8K in total portfolio value
10 years
XPPLF
XPPLF
● Live price
12.23%
Share price
$16.35
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$1.33
Full XPPLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — XPPLF vs JNJ

📍 XPPLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXPPLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XPPLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
XPPLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPPLF
Annual income on $10K today (after 15% tax)
$1,039.76/yr
After 10yr DRIP, annual income (after tax)
$1.13/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $702.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPPLF + JNJ for your $10,000?

XPPLF: 50%JNJ: 50%
100% JNJ50/50100% XPPLF
Portfolio after 10yr
$20.9K
Annual income
$414.55/yr
Blended yield
1.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

XPPLF
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
2.4
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPPLF buys
0
JNJ buys
0
No recent congressional trades found for XPPLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXPPLFJNJ
Forward yield12.23%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-50%5.8%
Portfolio after 10y$21.9K$20.0K
Annual income after 10y$1.33$827.78
Total dividends collected$1.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: XPPLF vs JNJ ($10,000, DRIP)

YearXPPLF PortfolioXPPLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,312$611.62$10,676$355.77+$636.00XPPLF
2$12,427$323.29$11,407$389.39+$1.0KXPPLF
3$13,463$165.96$12,198$426.53+$1.3KXPPLF
4$14,489$84.02$13,056$467.62+$1.4KXPPLF
5$15,545$42.25$13,987$513.12+$1.6KXPPLF
6$16,655$21.18$14,998$563.56+$1.7KXPPLF
7$17,831$10.61$16,098$619.52+$1.7KXPPLF
8$19,085$5.31$17,295$681.69+$1.8KXPPLF
9$20,423$2.65$18,599$750.82+$1.8KXPPLF
10$21,854$1.33$20,022$827.78+$1.8KXPPLF

XPPLF vs JNJ: Complete Analysis 2026

XPPLFStock

XP Power Limited, an investment holding company, designs and manufactures power supply solutions in Europe, North America, and Asia. The company offers AC-DC power supplies, DC-DC converters, high voltage DC-DC converters, high voltage AC-DC power supplies, RF power systems, EMI filters, custom power supplies, and 3 phase power sources. It also offers engineering services. The company serves healthcare, industrial technology, and semiconductor equipment manufacturing industries. XP Power Limited was founded in 1988 and is based in Singapore.

Full XPPLF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this XPPLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPPLF vs SCHDXPPLF vs JEPIXPPLF vs OXPPLF vs KOXPPLF vs MAINXPPLF vs ABBVXPPLF vs MRKXPPLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.